What is Rhythm Pharmaceuticals, Inc.'s FX effect on cash?

Rhythm Pharmaceuticals, Inc. (RYTM) reported FX effect on cash of $448K in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s FX effect on cash changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s FX effect on cash increased by 22500.0% year-over-year, from -$2K to $448K.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s FX effect on cash?

Over 2 years (2023 to 2025), Rhythm Pharmaceuticals, Inc.'s FX effect on cash has grown at a -21.7% compound annual growth rate (CAGR), from -$142K to $87K.

What does FX effect on cash mean?

The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.

Rhythm Pharmaceuticals, Inc. RYTM FX Effect on Cash

FX Effect on Cash at other companies

Eli LillyLLY

$67M-49.2%

Arrowhead ResearchARWR

$997K+348%

Roivant SciencesROIV

$1.32M—

Mirum Pharmaceuticals, Inc.MIRM

——

Ionis PharmaceuticalsIONS

——

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s FX effect on cash?: Rhythm Pharmaceuticals, Inc. (RYTM) reported FX effect on cash of $448K in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s FX effect on cash changed year-over-year?: Rhythm Pharmaceuticals, Inc.'s FX effect on cash increased by 22500.0% year-over-year, from -$2K to $448K.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s FX effect on cash?: Over 2 years (2023 to 2025), Rhythm Pharmaceuticals, Inc.'s FX effect on cash has grown at a -21.7% compound annual growth rate (CAGR), from -$142K to $87K.
What does FX effect on cash mean?: The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.